Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?-Reference-Cited by-同舟云学术

Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?

Published:2004 Issue:5 Volume:43 Page:523-533
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Pulsipher Michael A.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference58 articles.

1. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

2. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

3. Chronic Myelogenous Leukemia

4. Interferon Alfa Versus Chemotherapy for Chronic Myeloid Leukemia: A Meta-analysis of Seven Randomized Trials

5. Autografting With Philadelphia Chromosome–Negative Mobilized Hematopoietic Progenitor Cells in Chronic Myelogenous Leukemia

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group;British Journal of Haematology;2024-05-27

2. Phenolic Compounds – An Emerging Group of Natural Compounds against Leukaemia: in vitro, in vivo and Clinical Applications;Phenolic Compounds [Working Title];2021-07-28

3. Pretransplantation: Indications and Timing;Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist;2017-09-04

4. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis;Biology of Blood and Marrow Transplantation;2016-06

5. Profile of imatinib in pediatric leukemia;Pediatric Health, Medicine and Therapeutics;2014-02